COVID-19

BU investigators are working with colleagues in South Africa to assist the South African Government to manage the COVID-19 pandemic and collaborating on COVID-19 research in the U.S. and elsewhere.

Publications and other documents

Benade M, Long LC, Meyer-Rath G, Miot J, Evans D, Tucker JM, Moultrie H, Rosen S. Reduction in initiations of tuberculosis treatment in South Africa during the COVID pandemic. PLOS Global Public Health 2022; 2: e0000559. https://doi.org/10.1371/journal.pgph.0000559.

Chevalier JM, Sy KTL, Girdwood S, Khan S, Albert H, Toporowski A, Hannay E, Carmona S, Nichols B. Optimal use of COVID19 Ag-RDT screening at border crossings to prevent community transmission: a modeling analysis.

Benade M, Long L, Rosen S, Meyer-Rath G, Tucker JM, Miot J. Reduction in initiations of HIV treatment in South Africa during the COVID pandemic. BMC Health Serv Res. 2022 Mar 31;22(1):428. doi: 10.1186/s12913-022-07714-y. PMID: 35361209

Sy T, White LF, Nichols BE. Population density and basic reproductive number of COVID-19 across United States counties. PLOS One 2021;16(4): e0249271.

Edoka I, Fraser H, Jamieson L, Meyer-Rath G, Mdewa W. Inpatient care costs of COVID-19 in South Africa’s public healthcare system. Int J Health Pol Mgmt 2021.

Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G. The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity. Clin Infect Dis. 2020 Jul 6:ciaa937.

Jo Y, Jamieson L, Edoka I, Long L, Silal S, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE. Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa. Open Forum Inf Dis 2021.